Heterogeneity of PET/CT Imaging Phenotype Prognostic in mCRPC
Assessments of androgen receptor, glycolysis prognostic in castration-resistant prostate Cancer
Sentinel Lymph Node Biopsy Underused in High-Risk SCC
<0.1 percent of patients with high-risk SCC tumors underwent SLNB; 14 percent underwent dissections
Drug Combo Doesn’t Lengthen Glioblastoma Survival
Lomustine+bevacizumab may increase progression-free, but not overall, survival versus lomustine alone
Health Care Experts in Favor of Patient Contribution to Notes
With some cautions, experts are supportive of the OurNotes medical notes intervention
Insurance Underlies Black-White Survival Disparity in CRC
54 percent of excess risk of death in black colorectal cancer patients accounted for by insurance matching
ER- Breast CA Risk Up for African-Americans With T2DM
ER- type accounts for increased breast cancer risk in African-American women; highest risk in nonobese
Use of MMR Deficiency Testing in Younger CRC Patients Is Low
Just 43.1 percent underwent mismatch repair deficiency of DNA testing
About 20 Percent of U.S. Adults Currently Use Tobacco Products
Overall, 15.1 percent use cigarettes, with higher use among males, older adults, those with lower incomes
Oral Chemotherapy Parity Laws Offer Some Financial Protection
Decrease in estimated out-of-pocket spending at the 25th, 50th, 75th percentiles; increase at 90th, 95th
Adipocytes Metabolize, Inactivate Daunorubicin
Adipocytes metabolize daunorubicin to daunorubicinol, reducing its anti-leukemia effect
